Format

Send to

Choose Destination
J Invest Dermatol. 2014 Sep;134(9):2298-2300. doi: 10.1038/jid.2014.171.

From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases.

Author information

1
Department of Dermatology, University of Lübeck, Lübeck, Germany.
2
Department of Dermatology Inselspital, Bern University Hospital, Bern, Switzerland.
3
Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
4
Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan.
5
Department of Dermatology, Philipps University Marburg, Marburg, Germany.
6
Department of Dermatology, University of Groningen, Groningen, The Netherlands.
7
Department of Dermatology, Kizawa Memorial Hospital, Minokamo, Japan.
8
Department of Dermatology, St George Hospital, University of New South Wales, Sydney, New South Wales, Australia.
9
Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
10
Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
11
Department of Dermatology, The Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
12
Department of Dermatology, University of Lübeck, Lübeck, Germany. Electronic address: detlef.zillikens@uksh.de.
PMID:
25120143
DOI:
10.1038/jid.2014.171
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center